Assessment of simvastatin niosomes for pediatric transdermal drug delivery

References

• Ah YC, Choi JK, Choi YK, et al. (2010). A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 385:12–19
   PubMed Web of Science ®Google Scholar
• Alinchenko MG, Voloshin VP, Medvedev NN, et al. (2005). Effect of cholesterol on the properties of phospholipid membranes. 4. Interatomic voids. J Phys Chem B 109:16490–502
   PubMed Web of Science ®Google Scholar
• Alsarra IA. (2009). Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul 26:272–8
   PubMed Web of Science ®Google Scholar
• Amati L, Chiloiro M, Jirillo E, et al. (2007). Early pathogenesis of atherosclerosis: the childhood obesity. Curr Pharm Des 13:3696–700
   PubMed Web of Science ®Google Scholar
• Ammar HO, Salama HA, El-Nahhas SA, et al. (2008). Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv 5:290–8
   PubMedGoogle Scholar
• Arunothayanun P, Bernard MS, Craig DQ, et al. (2000). The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm 201:7–14
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
   PubMed Web of Science ®Google Scholar
• Bariya SH, Gohel MC, Mehta TA, et al. (2012). Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 64:11–29
   PubMed Web of Science ®Google Scholar
• Belay B, Belamarich PF, Tom-Revzon C. (2007). The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics 119:370–80
   PubMed Web of Science ®Google Scholar
• Browne B, Vasquez S. (2008). Pediatric dyslipidemias: prescription medication efficacy and safety. J Clin Lipidol 2:189–201
   PubMed Web of Science ®Google Scholar
• Casals E, Galán AM, Escolar G, et al. (2003). Physical stability of liposomes bearing hemostatic activity. Chem Phys Lipids 125:139–46
   PubMed Web of Science ®Google Scholar
• Ceballos LT, Angelín BP, García CR. (2008). Use of statins in children. An Pediatr 68:385–92
   Google Scholar
• Dahl-Jorgensen K, Larsen JR, Hanssen KF. (2005). Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 48:1445–53
   PubMed Web of Science ®Google Scholar
• Daniels SR, Greer FR, Committee on Nutrition. (2008). Lipid screening and cardiovascular health in childhood. Pediatrics 122:198–208
   PubMed Web of Science ®Google Scholar
• Das MK, Palei NN. (2011). Sorbitan ester niosomes for topical delivery of rofecoxib. Indian J Exp Biol 49:438–45
   PubMed Web of Science ®Google Scholar
• Disalvo EA, Bouchet AM. (2014). Electrophoretic mobility and zeta potential of liposomes due to arginine and polyarginine adsorption. Colloids Surf A: Physicochem Eng Asp 440:170–4
   Web of Science ®Google Scholar
• El-Menshawe SF, Hussein AK. (2013). Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Dev Technol 18:779–86
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140–8
   PubMed Web of Science ®Google Scholar
• El-Say KM, Ahmed TA, Badr-Eldin SM, et al. (2014). Enhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation. Pharm Dev Technol 2014 Jul 14:1–8. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Fang JY, Hwang TL, Huang YL, et al. (2006). Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 310:131–8
   PubMed Web of Science ®Google Scholar
• Franzen U, Ostergaard J. (2012). Physico-chemical characterization of liposomes and drug substance-liposome interactions in pharmaceutics using capillary electrophoresis and electrokinetic chromatography. J Chromatogr A 1267:32–44
   PubMed Web of Science ®Google Scholar
• Gambhire M, Bhalekar M, Shrivastava B. (2011). Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration. AJPS 6:251–8
   Google Scholar
• Gelissen IC, Nguyen HL, Tiao DK, et al. (2014). Statin use in Australian children: a retrospective audit of four pediatric hospitals. Paediatr Drugs 16:417–23
   PubMed Web of Science ®Google Scholar
• Hakanen M, Lagstrom H, Kaitosaari T, et al. (2006). Development of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP study. Int J Obes (Lond) 30:618–26
   PubMed Web of Science ®Google Scholar
• Hayashi T, Kanbe H, Okada M, et al. (2005). Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int J Pharm 304:91–101
   PubMed Web of Science ®Google Scholar
• Jiang T, Han N, Zhao B, et al. (2012). Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm 38:1230–9
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73
   PubMed Web of Science ®Google Scholar
• Knudsen NO, Ronholt S, Salte RD, et al. (2012). Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm 81:532–9
   PubMed Web of Science ®Google Scholar
• Leroy P, Devau N, Revil A, et al. (2013). Influence of surface conductivity on the apparent zeta potential of amorphous silica nanoparticles. J Colloid Interface Sci 410:81–93
   PubMed Web of Science ®Google Scholar
• Liang X, Mao G, Ng KY. (2004). Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J Colloid Interface Sci 278:53–62
   PubMed Web of Science ®Google Scholar
• Liu B, Mazouchi A, Gradinaru CC. (2010). Trapping single molecules in liposomes: surface interactions and freeze-thaw effects. J Phys Chem B 114:15191–8
   PubMed Web of Science ®Google Scholar
• Lyklema J, Minor M. (1998). On surface conduction and its role in electrokinetics. Colloids Surf A 140:33–41
   Web of Science ®Google Scholar
• Magin RL, Niesman MR. (1984). Temperature-dependent permeability of large unilamellar liposomes. Chem Phys Lipids 34:245–56
   PubMed Web of Science ®Google Scholar
• Matos SL, Paula HD, Pedrosa ML, et al. (2005). Dietary models for inducing hypercholesterolemia in rats. Braz Arch Biol Technol 48:203–9
   Web of Science ®Google Scholar
• Matsumura H, Verbich SV, Dimitrova MN. (2001). Surface conductivity of counter ions on protein-adsorbed lipid liposomes. Colloids Surf A: Physicochem Eng Asp 192:331–6
   Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Morgan TM, Reed BL, Finnin BC. (1998). Enhanced skin permeation of sex hormones with novel topical spray vehicles. J Pharm Sci 87:1213–18
   PubMed Web of Science ®Google Scholar
• Newman WP, III Freedman DS, Voors AW, et al. (1986). Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138–44
   PubMed Web of Science ®Google Scholar
• Pando D, Gutiérrez G, Coca J, et al. (2013). Preparation and characterization of niosomes containing resveratrol. J Food Eng 117:227–34
   Web of Science ®Google Scholar
• Pandya P, Gattani S, Jain P, et al. (2008). Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation. AAPS PharmSciTech 9:1247–52
   PubMed Web of Science ®Google Scholar
• Patty PJ, Frisken BJ. (2006). Direct determination of the number-weighted mean radius and polydispersity from dynamic light-scattering data. Appl Opt 45:2209–16
   PubMed Web of Science ®Google Scholar
• Pesonen E. (1989). Preliminary and early stages of atherosclerosis in childhood. Zentralbl Allg Pathol 135:545–8
   PubMedGoogle Scholar
• Revil A, Glover PWJ. (1997). Theory of ionic-surface electrical conduction in porous media. Phys Rev B 55:1757–73
   Web of Science ®Google Scholar
• Schwab KO, Doerfer J, Krebs A, et al. (2007). Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr 166:541–8
   PubMed Web of Science ®Google Scholar
• Sibley C, Stone NJ. (2006). Familial hypercholesterolemia: a challenge of diagnosis and therapy. Cleve Clin J Med 73:57–64
   PubMed Web of Science ®Google Scholar
• Smith DG. (2007). Epidemiology of dyslipidemia and economic burden on the healthcare system. Am J Manag Care 13:S68–71
   PubMed Web of Science ®Google Scholar
• Tavano L, Alfano P, Muzzalupo R, et al. (2011). Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin. Colloids Surf B Biointerfaces 87:333–9
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. (2011). Statins therapy: a review on conventional and novel formulation approaches. J Pharm Pharmacol 63:983–98
   PubMed Web of Science ®Google Scholar
• van Wijk JP, Buirma R, van Tol A, et al. (2005). Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis. Atherosclerosis 178:147–55
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tavakoli N, Salamat FA. (2011). Enhanced dissolution rate of simvastatin using spherical crystallization technique. Pharm Dev Technol 16:529–35
   PubMed Web of Science ®Google Scholar
• Who-Report. (2012). Country cooperation strategy for WHO and Saudi Arabia 2006-2011 [Online]. Available from: http://www.who.int/countryfocus/cooperation_strategy/ccs_sau_en.pdf [last accessed 20 May 2013]
   Google Scholar
• Woodbury DJ, Richardson ES, Grigg AW, et al. (2006). Reducing liposome size with ultrasound: bimodal size distributions. J Liposome Res 16:57–80
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. (2011). A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. Int J Pharm 419:52–9
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. (2012). A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. Int J Pharm 423:543–53
   PubMed Web of Science ®Google Scholar
• Yamaguchi T. (1996). Lipid microspheres as drug carriers: a pharmaceutical point of view. Adv Drug Deliv Rev 20:117–30
   Web of Science ®Google Scholar
• Yau WM, Wimley WC, Gawrisch K,et al. (1998). The preference of tryptophan for membrane interfaces. Biochemistry 37:14713–18
   PubMed Web of Science ®Google Scholar
• Zidan AS, Mokhtar M. (2011). Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics. J Pharm Sci 100:2212–21
   PubMed Web of Science ®Google Scholar
• Zidan AS, Rahman Z, Khan MA. (2011). Product and process understanding of a novel pediatric anti-HIV tenofovir niosomes with a high-pressure homogenizer. Eur J Pharm Sci 44:93–102
   PubMed Web of Science ®Google Scholar